12:00 AM
 | 
Mar 12, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

VibeX riboflavin ophthalmic solution regulatory update

Avedro submitted an NDA to FDA for VibeX riboflavin ophthalmic solution for use with its KXL System for corneal cross-linking...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >